Despite the establishment of an oncogene-centric molecular classification paradigm for this lung cancer [6], the precise role of p53 in NSCLC remains unclear, particularly in two of its primary subtypes with distinct cellular origins, namely, lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC). This evidence concerns the gene TP53 and lung carcinoma.